Try it
ENT · Oral cavity: radiation xerostomia
Sample itemA 58-year-old man who received radiotherapy to the neck for oropharyngeal cancer complains of persistent dry mouth. Which drug stimulates residual salivary function?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Pilocarpine
Pilocarpine is a muscarinic agonist that stimulates residual gland function and relieves radiation-induced xerostomia. Atropine and tricyclics worsen dryness. Intensity-modulated radiotherapy and amifostine reduce the damage before it occurs.
Option by option
A. Atropine
Atropine blocks muscarinic receptors and dries secretions.
B. Furosemide
Furosemide does not stimulate salivation.
C. Amitriptyline
Amitriptyline is anticholinergic and dries the mouth.
D. Pilocarpine (correct)
Correct. A muscarinic agonist increases salivation.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More ENT questions
- AudiologyIn a tuning fork test, Rinne is negative (bone conduction louder than air conduction) in…
- EarWhich type of chronic suppurative otitis media is considered 'unsafe'?
- LarynxIn singers, vocal nodules typically occur at:
- Vestibular disordersA patient has recurrent attacks of vertigo lasting hours, with fluctuating low-frequency…